ROI Boosts Radiation Oncology Through Research
Six of the best and brightest investigative teams are joining the distinguished group of ROI grant recipients as the winners of this year’s Leveraging Artificial Intelligence (AI) for Radiation Oncology Awards. ROI selected AI as the topic for our most recent request for proposals (RFP) to cultivate an emerging technology that has the potential to transform practice. Many in the radiation oncology community see great promise in using AI to improve the quality of care and increase personalization of treatment and streamline clinical workflow. As such, applicants submitted a large number of excellent proposals.
ROI issued its first RFP ten years ago, and each one has been developed to address timely and practical needs of the specialty. The AI awards are just the latest example of how ROI is at the forefront of innovative and exciting research to advance radiation oncology. Other current ROI researchers are seeking solutions to key challenges facing the field such as improving diversity and inclusion and developing biomarkers for radiation oncology.
The ROI’s Research Agenda has provided a foundation for the more than $4 million in research funded to date and is based on the results of a comprehensive research needs assessment commissioned by ROI. The Research Agenda has served ROI well over the past decade, but to ensure we are funding the highest priority research for radiation oncology, we have embarked upon an update through an iterative survey process. Later this year, we will request your input on what you believe are the most pressing areas of research for ROI to fund. We look forward to hearing from the radiation oncology community and incorporating your thoughts into the next Research Agenda that will help guide the future of ROI research.
ROI is committed to supporting investigators who are improving outcomes for patients through innovative and relevant research, and I hope you will join me in celebrating our new Leveraging AI for Radiation Oncology Award winners. These grants are made possible through the generosity of ROI donors, and you can help continue to advance radiation oncology research by making your contribution today.
Robert C. Miller, MD, MBA, FASTRO
ROI Research Committee Chair and Trustee